Simultaneous Evaluation of Viability and BCL-2 in Small-Cell Lung Cancer

Cytometry Part A - United Kingdom
doi 10.1002/cyto.a.20634
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

P2.01-83 Evaluation of Dynamic Thiol/Disulphide Homeostasis in Advance Non-Small Cell Lung Cancer and Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Venetoclax Is Effective in Small Cell Lung Cancers With High BCL-2 Expression

Clinical Cancer Research
Cancer ResearchOncology
2017English

Prognostic Value of BCL-2 Expression in Patients With Non-Small-Cell Lung Cancer: A Meta-Analysis and Systemic Review

OncoTargets and Therapy
OncologyPharmacology
2015English

MicroRNA-630 May Confer Favorable Cisplatin-Based Chemotherapy and Clinical Outcomes in Non-Small Cell Lung Cancer by Targeting BCL-2

Oncotarget
Oncology
2018English

miR-296-5p Suppresses Cell Viability by Directly Targeting PLK1 in Non-Small Cell Lung Cancer

Oncology Reports
MedicineCancer ResearchOncology
2015English

Small-Cell Lung Cancer

Medical Herald of the South of Russia
2017English

Small Cell Lung Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1989English

Comparison of Primary Tumor SUVmax Between Small Cell Lung Cancer and Non-Small Cell Lung Cancer

Current Trends in Clinical & Medical Imaging
2019English

Bevacizumab in Small Cell Lung Cancer

Annals of Translational Medicine
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy